Evidence map›Paper›PMID 24434788›Full record

ArticleAutophagy2014

The emerging potential of autophagy-based therapies in the treatment of cystic fibrosis lung infections.

Robert D Junkins, Craig McCormick, Tong-Jun Lin

Open access · hybridAbstract readComment
In one paragraph

Article in Autophagy, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. A SNARE protein Syntaxin 17 captures CFTR to potentiate autophagosomal clearance under stress.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Oxidative stress, autophagy and airway ion transport.American journal of physiology. Cell physiology · 2019
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Autophagy mediates oral submucous fibrosis.Experimental and therapeutic medicine · 2016
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Robert D JunkinsDepartment of Microbiology and Immunology; Dalhousie University; Halifax, NS CA; Department of Pediatrics; IWK Health Centre; Halifax, NS CA; Beatrice Hunter Cancer Research Institute; Halifax, NS CA.
Craig McCormickDepartment of Microbiology and Immunology; Dalhousie University; Halifax, NS CA; Beatrice Hunter Cancer Research Institute; Halifax, NS CA.
Tong-Jun LinDepartment of Microbiology and Immunology; Dalhousie University; Halifax, NS CA; Department of Pediatrics; IWK Health Centre; Halifax, NS CA; Beatrice Hunter Cancer Research Institute; Halifax, NS CA.
Beatrice Hunter Cancer Research Institute · CADalhousie University · CAIzaak Walton Killam Health Centre · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cystic fibrosis (CF) is caused by mutations in the CF transmembrane conductance regulator (CFTR), a channel that normally transports anions across epithelial cell membranes. The most common manifestation of CF is buildup of mucus in the airways and bacterial colonization of the lower respiratory tract, accompanied by chronic inflammation. Antibiotics are used to control CF-associated opportunistic infections, but lengthy antibiotic treatment risks the emergence of multiple-drug resistant (MDR) strains. New antimicrobial strategies are needed to prevent and treat infections in these high-risk individuals. Autophagy contributes to the control of a variety of microbial infections. For this reason, the recent discovery of functional impairment of autophagy in CF provides a new basis for understanding susceptibility to severe infections. Here, we review the role of autophagy in host defense against CF-associated bacterial and fungal pathogens, and survey pharmacologic approaches to restore normal autophagy function in these individuals. Autophagy restoration therapy may improve pathogen clearance and mitigate lung inflammation in CF airways.

Indexed as

AnimalsAutophagyHumansMast CellsPneumonia, BacterialPseudomonas aeruginosaPseudomonas InfectionsA. fumigatusautophagyB. cepaciaBECN1cystic fibrosisH. influenzanon-tuberculosis mycobacteriumP. aeruginosarapamycinS. aureusTGM2

Identifiers

PMID24434788
PMCPMC4077897
OpenAlexW2058742845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.